Literature DB >> 20190304

Proximal femoral allograft-prosthesis composites in revision hip replacement: a 12-year follow-up study.

G C Babis1, V I Sakellariou, M I O'Connor, A D Hanssen, F H Sim.   

Abstract

We report the use of an allograft prosthetic composite for reconstruction of the skeletal defect in complex revision total hip replacement for severe proximal femoral bone loss. Between 1986 and 1999, 72 patients (20 men, 52 women) with a mean age of 59.9 years (38 to 78) underwent reconstruction using this technique. At a mean follow-up of 12 years (8 to 20) 57 patients were alive, 14 had died and one was lost to follow-up. Further revision was performed in 19 hips at a mean of 44.5 months (11 to 153) post-operatively. Causes of failure were aseptic loosening in four, allograft resorption in three, allograft nonunion in two, allograft fracture in four, fracture of the stem in one, and deep infection in five. The survivorship of the allograft-prosthesis composite at ten years was 69.0% (95% confidence interval 67.7 to 70.3) with 26 patients remaining at risk. Survivorship was statistically significantly affected by the severity of the pre-operative bone loss (Paprosky type IV; p = 0.019), the number of previous hip revisions exceeding two (p = 0.047), and the length of the allograft used (p = 0.005).

Entities:  

Mesh:

Year:  2010        PMID: 20190304     DOI: 10.1302/0301-620X.92B3.23112

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  17 in total

Review 1.  Management of periprosthetic femoral fractures following total hip arthroplasty: a review.

Authors:  Matthew P Abdel; Umberto Cottino; Tad M Mabry
Journal:  Int Orthop       Date:  2015-08-29       Impact factor: 3.075

Review 2.  Megaprosthesis versus Allograft Prosthesis Composite for massive skeletal defects.

Authors:  Deepak Gautam; Rajesh Malhotra
Journal:  J Clin Orthop Trauma       Date:  2017-09-25

3.  Cementless femoral revision in patients with a previous cemented prosthesis.

Authors:  Min Zeng; Jie Xie; Mingqing Li; Shaoru Lin; Yihe Hu
Journal:  Int Orthop       Date:  2015-02-19       Impact factor: 3.075

4.  Long-term functional and radiological outcomes of allograft hip prosthesis composite. A fourteen -year follow-up study.

Authors:  Arnaud Dubory; Eric Mascard; Méryl Dahan; Philippe Anract; Charles Court; Stéphane Boisgard; Brice Viard; Gilles Missenard
Journal:  Int Orthop       Date:  2016-12-03       Impact factor: 3.075

5.  CT Lesion Model-Based Structural Allografts: Custom Fabrication and Clinical Experience.

Authors:  Jan Claas Brune; Uwe Hesselbarth; Philipp Seifert; Dimitri Nowack; Rüdiger von Versen; Mark David Smith; Dirk Seifert
Journal:  Transfus Med Hemother       Date:  2012-11-13       Impact factor: 3.747

Review 6.  [Importance of revision- and tumor-endoprosthetics in the treatment of periprosthetic fractures of the lower extremity].

Authors:  P M Prodinger; N Harrasser; C Suren; F Pohlig; H Mühlhofer; J Schauwecker; R von Eisenhart-Rothe
Journal:  Unfallchirurg       Date:  2016-04       Impact factor: 1.000

Review 7.  Management bone loss of the proximal femur in revision hip arthroplasty: Update on reconstructive options.

Authors:  Vasileios I Sakellariou; George C Babis
Journal:  World J Orthop       Date:  2014-11-18

8.  The combined effect of parathyroid hormone and bone graft on implant fixation.

Authors:  H Daugaard; B Elmengaard; T T Andreassen; J Baas; J E Bechtold; K Soballe
Journal:  J Bone Joint Surg Br       Date:  2011-01

9.  High Survivorship With Cementless Stems and Cortical Strut Allografts for Large Femoral Bone Defects in Revision THA.

Authors:  Young-Hoo Kim; Jang-Won Park; Jun-Shik Kim; Devarshi Rastogi
Journal:  Clin Orthop Relat Res       Date:  2015-05-27       Impact factor: 4.176

10.  Oncologic and clinical outcomes in pelvic primary bone sarcomas treated with limb salvage surgery.

Authors:  G L Farfalli; J I Albergo; L E Ritacco; M A Ayerza; D L Muscolo; L A Aponte-Tinao
Journal:  Musculoskelet Surg       Date:  2015-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.